Articles scientifiques

GANDAR J, BONYOHE M, EBAH A, TABEBOT A, MILLOGO T, KAMWA S, BISSEK PAnne-Cecil.  2025.  Protecting Our Newborns : Strategies to combat stillbirths and neonatal deaths in Cameroon.

Anoubissi Jde Dieu, Gabriel ELoni, Nde CKengne, Fokam J, Tseuko DGodelive, Messeh A, Moussa Y, Nkenfou CNguefeu, Bonono L, Billong S-C et al..  2019.  Factors associated with risk of HIV-infection among pregnant women in Cameroon: Evidence from the 2016 national sentinel surveillance survey of HIV and syphilis.. PLoS One. 14(4):e0208963.

Penda CIda, Ndongo FA, Bissek A-CZ-K, Téjiokem MC, Sofeu C, Eboumbou ECMoukoko, Mindjouli S, Desmonde S, Njock LR.  2019.  Practices of Care to HIV-Infected Children: Current Situation in Cameroon.. Clin Med Insights Pediatr. 13:1179556519846110.

Sakwe N, Bigoga J, Ngondi J, Njeambosay B, Esemu L, Kouambeng C, Nyonglema P, Seumen C, Gouado I, Oben J.  2019.  Relationship between malaria, anaemia, nutritional and socio-economic status amongst under-ten children, in the North Region of Cameroon: A cross-sectional assessment.. PLoS One. 14(6):e0218442.

Billong SC, Dee J, Fokam J, Nguefack-Tsague G, Ekali GL, Fodjo R, Temgoua ES, Billong E-J, Sosso SM, Mosoko JJ et al..  2017.  Feasibility Study of HIV Sentinel Surveillance using PMTCT data in Cameroon: from Scientific Success to Programmatic Failure.. BMC Infect Dis. 17(1):3.

Fokam J, Billong SClotaire, Jogue F, Ndiang SMoyo Tetan, Motaze ACarole Nga, Paul KNdombo, Nlend AEsther Njo.  2017.  Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.. PLoS One. 12(11):e0187566.

Tabah ENjih, Nsagha DShey, Bissek A-CZoung-Kany, Njamnshi AKongnyu, Bratschi MW, Pluschke G, Boock AUm.  2016.  Buruli Ulcer in Cameroon: The Development and Impact of the National Control Programme.. PLoS Negl Trop Dis. 10(1):e0004224.

Kouotou EArmand, Folefack FKaze, Tatsa JTameyi, Sieleunou I, Njingang JRichie Nan, Ashuntantang G, Bissek A-CZoung-Kany.  2016.  [Epidemiological and clinical profile of skin damages in black African patients on chronic hemodialysis].. Pan Afr Med J. 25:142.

Serris A, Zoungrana J, Diallo M, Toby R, Ngolle MMpoudi, Le Gac S, Coutherut J, Cournil A, De Beaudrap P, Koulla-Shiro S et al..  2016.  Getting pregnant in HIV clinical trials: women's choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials.. HIV Clin Trials. 17(6):233-241.

Galy A, Ciaffi L, Le Moing V, Eymard-Duvernay S, Abessolo H, Toby R, Ayangma L, Le Gac S, Mpoudi-Etame M, Koulla-Shiro S et al..  2016.  Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.. Antivir Ther. 21(6):547-552.

Bissek A-CZoung-Kany, Tabah ENjih, Kouotou E, Sini V, Yepnjio FN, Nditanchou R, Nchufor RN, Defo D, Dema F, Fonsah JY et al..  2012.  The spectrum of skin diseases in a rural setting in Cameroon (sub-Saharan Africa).. BMC Dermatol. 12:7.

Nsagha DS, Bissek A-CZK, Nsagha SM, Njunda AL, Assob JCN, Tabah EN, Bamgboye EA, Oyediran ABankole O, Nde PF, Njamnshi AK.  2011.  Social stigma as an epidemiological determinant for leprosy elimination in Cameroon.. J Public Health Afr. 2(1):e10.